Literature DB >> 10602016

Enrichment and detection of live antigen-specific CD4(+) and CD8(+) T cells based on cytokine secretion.

H Brosterhus1, S Brings, H Leyendeckers, R A Manz, S Miltenyi, A Radbruch, M Assenmacher, J Schmitz.   

Abstract

Following appropriate antigen-specific stimulation, CD4(+) and CD8(+) T lymphocytes rapidly express cytokines. Based on this stimulation-induced cytokine secretion and using cell surface affinity matrix technology we have developed a new method that permits specific, rapid and efficient detection, isolation and characterization of live antigen-specific CD4(+) and CD8(+) T lymphocytes. The power of this technique is demonstrated here for HLA-A0201-restricted influenza matrix protein peptide 58-66-specific CD8(+) cytotoxic T lymphocytes, influenza A virus- and recombinant tetanus toxin C fragment-specific Th1 cells and tetanus toxoid-specific Th2 cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602016     DOI: 10.1002/(SICI)1521-4141(199912)29:12<4053::AID-IMMU4053>3.0.CO;2-C

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  41 in total

Review 1.  Recent developments in flow cytometry.

Authors:  A Scheffold; F Kern
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

Review 2.  Development and use of multimeric major histocompatibility complex molecules.

Authors:  Tim F Greten; Jonathan P Schneck
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

3.  Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells.

Authors:  Michaela Lucas; Cheryl L Day; Jessica R Wyer; Sharon L Cunliffe; Andrew Loughry; Andrew J McMichael; Paul Klenerman
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

4.  Lineage specificity of gene expression patterns.

Authors:  Yuval Kluger; David P Tuck; Joseph T Chang; Yasuhiro Nakayama; Ranjana Poddar; Naohiko Kohya; Zheng Lian; Abdelhakim Ben Nasr; H Ruth Halaban; Diane S Krause; Xueqing Zhang; Peter E Newburger; Sherman M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

5.  Ex vivo monitoring of antigen-specific CD4+ T cells after recall immunization with tetanus toxoid.

Authors:  Catherine Barbey; Estelle Pradervand; Nathalie Barbier; François Spertini
Journal:  Clin Vaccine Immunol       Date:  2007-07-18

6.  Estimation of low frequency antigen-presenting cells with a novel RELISPOT assay.

Authors:  Amiran K Dzutsev; Igor M Belyakov; Dmitry V Isakov; Susan J Gagnon; David H Margulies; Jay A Berzofsky
Journal:  J Immunol Methods       Date:  2008-02-08       Impact factor: 2.303

7.  CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy.

Authors:  Kazue Watanabe; Susumu Suzuki; Michi Kamei; Shingo Toji; Takakazu Kawase; Toshitada Takahashi; Kiyotaka Kuzushima; Yoshiki Akatsuka
Journal:  Int J Hematol       Date:  2008-08-05       Impact factor: 2.490

8.  Impact of T cell selection methods in the success of clinical adoptive immunotherapy.

Authors:  Natalia Ramírez; Lorea Beloki; Miriam Ciaúrriz; Mercedes Rodríguez-Calvillo; David Escors; Cristina Mansilla; Eva Bandrés; Eduardo Olavarría
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.261

Review 9.  Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?

Authors:  Christopher A Klebanoff; Luca Gattinoni; Nicholas P Restifo
Journal:  J Immunother       Date:  2012 Nov-Dec       Impact factor: 4.456

10.  Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides.

Authors:  Daniel E Kaufmann; Paul M Bailey; John Sidney; Bradford Wagner; Philip J Norris; Mary N Johnston; Lisa A Cosimi; Marylyn M Addo; Mathias Lichterfeld; Marcus Altfeld; Nicole Frahm; Christian Brander; Alessandro Sette; Bruce D Walker; Eric S Rosenberg
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.